Janette Guertin
Acute Care · Port Huron, MINPI 1619361870
Payments from drug & device makers
Across 788 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- Livanova USA, Inc.$1K
- Biogen$1K
- UCB, Inc.$938
- Amgen$868
- plus $7K from 46 others
What the payments were for
- Travel & lodging$8856%
- Food & beverage$12,79193%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,248
- PURIFIED CORTROPHIN GEL$113
How this compares
$13,719 in reported general payments places this provider in the 95th percentile of 567 acute care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VumerityDiroximel Fumarate | 75 | $629,347 |
| Kesimpta PenOfatumumab | 25 | $204,953 |
| GilenyaFingolimod Hcl | 13 | $131,750 |
| BriviactBrivaracetam | 27 | $49,926 |
| AmpyraDalfampridine | 11 | $45,530 |
| UbrelvyUbrogepant | 29 | $26,708 |
| RexultiBrexpiprazole | 14 | $24,972 |
| QuliptaAtogepant | 16 | $21,878 |
| Nurtec OdtRimegepant Sulfate | 16 | $21,153 |
| Emgality PenGalcanezumab-Gnlm | 25 | $21,058 |
| AptiomEslicarbazepine Acetate | 16 | $21,056 |
| NayzilamMidazolam | 14 | $13,732 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 838 | $13,222 |
| Pregabalin | 417 | $9,509 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $7,967 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BiogenVumerity | $1,233 | $629,34775 claims |
| NovartisGilenya | $1,310 | $131,75013 claims |
| UCB, Inc.Briviact, Nayzilam | $938 | $63,65841 claims |
| AbbVieUbrelvy, Qulipta | $1,472 | $48,58645 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $151 | $24,97214 claims |
| PfizerNurtec Odt | $526 | $21,15316 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $26 | $21,05616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 567 acute care providers in Michigan.
Other acute care in Port Huron
- Candise LovePort Huron$14K
- Amy StoreyPort Huron$4K
- Stephanie CastellanaPort Huron$3K
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.